Company intelligence / Profile preview

PatenSee

Or Yehuda, Israel

Ownership: Private
Development stage: Other

Overview

PatenSee is conducting clinical pilots and trials for FDA clearance, with first-in-human trials initiated and collaborations ongoing; commercial launch targeted for 2026.[1][2][4]

Therapeutic areas: Nephrology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Fresenius Medical Care

Beyond the preview

Go deeper on PatenSee.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PatenSee.

Explore the full profile